Literature DB >> 15100095

Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension.

V Matti Vehaskari1, Tyrus Stewart, Derek Lafont, Christopher Soyez, Dale Seth, Jennifer Manning.   

Abstract

Adult hypertension may be programmed by the prenatal environment in humans and in experimental animals. The potential role of the intrarenal renin-angiotensin system (RAS) in prenatally programmed hypertension was investigated. Hypertension in rat offspring was induced by maternal protein restriction during pregnancy. The offspring were studied on day 1 of life and immediately preceding the development of hypertension on day 28. ANG I and II contents were determined by radioimmunoassy. Angiotensin receptor protein and mRNA levels were quantified by immunoblotting and real-time RT-PCR, respectively. Plasma and kidney ANG I and II were unchanged in the offspring from low-protein pregnancies (LP). ANG II type 1 receptor (AT(1)R) protein abundance was low in the newborn LP kidney (P < 0.05) but rose above control values by 28 days of age (P < 0.05); the rise was associated with an increase in AT(1)R subtype A (P < 0.01), but not subtype B, mRNA level. ANG II type 2 receptor protein expression was decreased on day 1 (P < 0.05) and increased on day 28 (P < 0.05) in LP kidneys. The results show that prenatal programming of hypertension is associated with an abnormal pattern of intrarenal RAS ontogeny that may play a pathogenetic role, for instance, by constitutively altering renal hemodynamics or Na reabsorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100095     DOI: 10.1152/ajprenal.00055.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  48 in total

Review 1.  Prenatal programming-effects on blood pressure and renal function.

Authors:  Eberhard Ritz; Kerstin Amann; Nadezda Koleganova; Kerstin Benz
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

2.  Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero.

Authors:  Vandana Sahajpal; Nick Ashton
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

3.  Temporal alterations in vascular angiotensin receptors and vasomotor responses in offspring of protein-restricted rat dams.

Authors:  Kunju Sathishkumar; Meena Balakrishnan; Vijayakumar Chinnathambi; Haijun Gao; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2012-04-06       Impact factor: 8.661

4.  Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring.

Authors:  Reetu R Singh; Luise A Cullen-McEwen; Michelle M Kett; Wee-Ming Boon; John Dowling; John F Bertram; Karen M Moritz
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 5.  Intrauterine growth restriction: fetal programming of hypertension and kidney disease.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Adv Chronic Kidney Dis       Date:  2008-04       Impact factor: 3.620

Review 6.  How the kidney is impacted by the perinatal maternal environment to develop hypertension.

Authors:  Ana D Paixão; Barbara T Alexander
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

Review 7.  Early life obesity and chronic kidney disease in later life.

Authors:  Hyung Eun Yim; Kee Hwan Yoo
Journal:  Pediatr Nephrol       Date:  2014-08-22       Impact factor: 3.714

Review 8.  Role of renal sympathetic nerve activity in prenatal programming of hypertension.

Authors:  Michel Baum
Journal:  Pediatr Nephrol       Date:  2016-03-21       Impact factor: 3.714

9.  Intrauterine growth restriction programs an accelerated age-related increase in cardiovascular risk in male offspring.

Authors:  John Henry Dasinger; Suttira Intapad; Miles A Backstrom; Anthony J Carter; Barbara T Alexander
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-04

10.  Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension.

Authors:  Hossam A Shaltout; Jorge P Figueroa; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Hypertension       Date:  2008-12-01       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.